These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17574687)

  • 1. Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling.
    Vermeiren H; Van Craenenbroeck E; Alen P; Bacheler L; Picchio G; Lecocq P;
    J Virol Methods; 2007 Oct; 145(1):47-55. PubMed ID: 17574687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical cut-offs for HIV-1 phenotypic resistance estimates: update based on recent pivotal clinical trial data and a revised approach to viral mixtures.
    Winters B; Van Craenenbroeck E; Van der Borght K; Lecocq P; Villacian J; Bacheler L
    J Virol Methods; 2009 Dec; 162(1-2):101-8. PubMed ID: 19654022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of artificial neural networks for phenotypic drug resistance prediction: evaluation and comparison with other interpretation systems.
    Pasomsub E; Sukasem C; Sungkanuparph S; Kijsirikul B; Chantratita W
    Jpn J Infect Dis; 2010 Mar; 63(2):87-94. PubMed ID: 20332568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nine resistance interpretation systems for HIV-1 genotyping.
    Stürmer M; Doerr HW; Staszewski S; Preiser W
    Antivir Ther; 2003 Jun; 8(3):239-44. PubMed ID: 12924541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
    Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate prediction of HIV-1 drug response from the reverse transcriptase and protease amino acid sequences using sparse models created by convex optimization.
    Rabinowitz M; Myers L; Banjevic M; Chan A; Sweetkind-Singer J; Haberer J; McCann K; Wolkowicz R
    Bioinformatics; 2006 Mar; 22(5):541-9. PubMed ID: 16368772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-parametric methods to predict HIV drug susceptibility phenotype from genotype.
    DiRienzo AG; DeGruttola V; Larder B; Hertogs K
    Stat Med; 2003 Sep; 22(17):2785-98. PubMed ID: 12939786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation.
    Zhang M; Han XX; Cui WG; Jia MH; Meng XD; Xing AH; Wu YH; Yang YY; Lu CM; Hu QH; Dai D; Zhang ZN; Shang H
    Jpn J Infect Dis; 2008 Sep; 61(5):361-5. PubMed ID: 18806342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment.
    Prosperi MC; Altmann A; Rosen-Zvi M; Aharoni E; Borgulya G; Bazso F; Sönnerborg A; Schülter E; Struck D; Ulivi G; Vandamme AM; Vercauteren J; Zazzi M;
    Antivir Ther; 2009; 14(3):433-42. PubMed ID: 19474477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection.
    Flandre P; Chappey C; Marcelin AG; Ryan K; Maa JF; Bates M; Seekins D; Bernard MC; Calvez V; Molina JM
    J Infect Dis; 2007 Feb; 195(3):392-8. PubMed ID: 17205478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir.
    Vergani B; Cicero ML; Vigano' O; Sirianni F; Ferramosca S; Vitiello P; Di Vincenzo P; Pia De Pasquale M; Galli M; Rusconi S
    J Clin Virol; 2008 Feb; 41(2):154-9. PubMed ID: 18024202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis of variation in tenofovir drug susceptibility in HIV-1.
    Murray RJ; Lewis FI; Miller MD; Brown AJ
    AIDS; 2008 Jun; 22(10):1113-23. PubMed ID: 18525256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
    Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A;
    Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype.
    Van Houtte M; Picchio G; Van Der Borght K; Pattery T; Lecocq P; Bacheler LT
    J Med Virol; 2009 Oct; 81(10):1702-9. PubMed ID: 19697398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania.
    Paraschiv S; Otelea D; Baicus C; Tinischi M; Costache M; Neaga E
    Int J Infect Dis; 2009 Jan; 13(1):81-9. PubMed ID: 18632295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients.
    Wirden M; Lambert-Niclot S; Marcelin AG; Schneider L; Ait-Mohand H; Brunet C; Angleraud F; Amard S; Katlama C; Calvez V
    AIDS; 2009 Jan; 23(1):95-9. PubMed ID: 19050391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the comparison of artificial network and interpretation systems based on genotype resistance mutations in HIV-1-infected patients.
    Flandre P; Costagliola D
    AIDS; 2006 Oct; 20(16):2118-20. PubMed ID: 17053360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of antiretroviral drug genotypic resistance among HIV patients in Cuenca, Spain].
    Rodriguez-Escudero MJ; Prada de Medio E; Rosa Herranz C; Martinez Medina MC; Franquelo Gutierrez R
    Rev Esp Quimioter; 2007 Jun; 20(2):203-5. PubMed ID: 17893756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.